Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2021 Earnings

29AprConfirmed

Q3 2020

Q4 2020

Q1 2021

Q2 2021

-12.04

-10.8

-9.56

-8.32

Details

Expected EPS

-9.6057

Actual EPS

-9.125415

Surprise EPS

0.48

Surprise Percent

+5%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -9.125415 per share for Q2 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.